CURX

Healthcare Biotechnology

Curanex Pharmaceuticals Inc

$4.99

+0.03 +0.60% today

Price History

Not enough data

Key Stats

Market Cap

7.83M

Avg Volume

17,389

EPS

-$8.33

52W High

$16.94

52W Low

$3.58

Div. Yield

0.0%

Valuation

P/B Ratio

1.48

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(411.1%)

Return on Assets

(225.1%)

Liquidity & Leverage

Current Ratio

45.95

Quick Ratio

28.17

Debt / Equity

0.06

Total Cash

2.94M

Total Debt

276,359

About

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.